Vertex Pharmaceuticals (VRTX) P/E ratio

P/E ratio today
34.4×

Vertex Pharmaceuticals (VRTX) trades at 34.4× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 29.6×. Today's figure is 16.2% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 07:27 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
34.4×
P/E ratio, fiscal 2025
29.6×
Highest on record
237.2×fiscal 2011
Lowest on record
20.5×fiscal 2018
Fiscal years on record
92011–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Vertex Pharmaceuticals P/E ratio, in more detail

Across the 9 fiscal year-ends on record (2011–2025), the highest was 237.2× in fiscal 2011 and the lowest 20.5× in fiscal 2018. Today's P/E ratio is higher than at 67% of the 9 fiscal year-ends on record; their median is 29.3×.

History · 9 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Vertex Pharmaceuticals P/E ratio, year by year

Vertex Pharmaceuticals (VRTX) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today34.4×—$534.20—
202529.6×—$453.36$15.32
2024——$402.70-$2.08
202329.3× 30.0% up$406.89$13.89
202222.5× 7.6% down$288.78$12.82
202124.4× 6.1% up$219.60$9.01
202023.0× 52.7% down$236.34$10.29
201948.5× 137.0% up$218.95$4.51
201820.5× 85.8% down$165.71$8.09
2017144.1×—$149.86$1.04
2016——$73.67-$0.46
2015——$125.83-$2.31
2014——$118.80-$3.14
2013——$74.30-$1.98
2012——$41.90-$0.50
2011237.2×—$33.21$0.14
2010——$35.03-$3.77
2009——$42.85-$3.71
2008——$30.38-$3.27

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of Vertex Pharmaceuticals and comparable companies
CompanyP/E ratio
Pfizer PFE40.7×
Danaher DHR37.4×
Intuitive Surgical ISRG52.1×
Vertex Pharmaceuticals VRTX34.4×
Medtronic MDT25.1×
Bristol-Myers Squibb BMY13.6×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on VRTX

Vertex Pharmaceuticals, figure by figure

Vertex Pharmaceuticals (VRTX) overview: price, valuation and scorecardAll health care companies by market value

Vertex Pharmaceuticals P/E ratio: questions and answers

What is Vertex Pharmaceuticals's P/E ratio?

Vertex Pharmaceuticals (VRTX) trades at 34.4× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 29.6×.

Is Vertex Pharmaceuticals's P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 67% of the 9 fiscal year-ends on record; their median is 29.3×.

What are the highest and lowest P/E ratio figures on record for Vertex Pharmaceuticals?

Across the 9 fiscal year-ends on record (2011–2025), the highest was 237.2× in fiscal 2011 and the lowest 20.5× in fiscal 2018.

How is Vertex Pharmaceuticals's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Vertex Pharmaceuticals (VRTX) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/VRTX/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.